Ka-wing Cheng

Prof. Ka-wing Cheng

Institute for Advanced Study, Shenzhen University, Shenzhen 518960, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2022 in Food Research International
Verified
Journal Article
Closed access
ANAsad Nawaz
Asad Nawaz
SISana Irshad
Sana Irshad
IKIftikhar Ali Khan
Iftikhar Ali Khan
Ibrahim KhalifaIbrahim Khalifa
Ibrahim Khalifa
Noman WalayatNoman Walayat
Noman Walayat
Jose Manuel LorenzoJose Manuel Lorenzo
Jose Manuel Lorenzo

1 May 2021 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
NZNana Zhang
Nana Zhang
QZQian Zhou
Qian Zhou
DFDaming Fan
Daming Fan
JXJianbo Xiao
Jianbo Xiao
YZYueliang Zhao
Yueliang Zhao
Mingfu WangMingfu Wang
Mingfu Wang

19 October 2021 in Comprehensive Reviews in Food Science and Food Safety
Verified
Journal Article
Open access
PDF file
MSMohammad Rezaul Islam Shishir
Mohammad Rezaul Islam Shishir
VGVemana Gowd
Vemana Gowd
HSHao Suo
Hao Suo
Mingfu WangMingfu Wang
Mingfu Wang
QWQiang Wang
Qiang Wang
Ka-wing ChengKa-wing Cheng
Ka-wing Cheng
Many important food bioactive compounds are plant secondary metabolites that have traditional applications for health promotion and disease prevention. However, the chemical instability and poor bioavailability of these compounds represent major challenges to researchers. In the last decade, therefore, major impetus has been given for the research and development of advanced carrier systems for the delivery of natural bioactive molecules. Among them, stimuli‐responsive carriers hold great promise for simultaneously improving stability, bioavailability, and more importantly delivery and on‐demand release of intact bioactive phytochemicals to target sites in response to certain stimuli or combination of them (e.g., pH, temperature, oxidant, enzyme, and irradiation) that would eventually enhance therapeutic outcomes and reduce side effects. Hybrid formulations (e.g., inorganic–organic complexes) and multi‐stimuli‐responsive formulations have demonstrated great potential for future studies. Therefore, this review systematically compiles and assesses the recent advances on the smart delivery of food bioactive compounds, particularly quercetin, curcumin, and resveratrol through stimuli‐responsive carriers, and critically reviews their functionality, underlying triggered‐release mechanism, and therapeutic potential. Finally, major limitations, contemporary challenges, and possible solutions/future research directions are highlighted. Much more research is needed to optimize the processing parameters of existing formulations and to develop novel ones for lead food bioactive compounds to facilitate their food and nutraceutical applications.

31 July 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
Bingbing GuoBingbing Guo
Bingbing Guo
BYBo Yang
Bo Yang
Xiaoyang PangXiaoyang Pang
Xiaoyang Pang
TCTianpeng Chen
Tianpeng Chen
Feng ChenFeng Chen
Feng Chen
Ka-wing ChengKa-wing Cheng
Ka-wing Cheng
Obesity is a major health concern worldwide and is considered to be associated with disruption of host-microbial homeostasis, especially microbiota composition in the gastrointestinal tract. Use of microbiota-directed foods or nutraceuticals therefore represents a promising approach for the control of obesity. Fucoxanthin, a marine carotenoid, has been proven to be one of the most effective anti-obesity natural products. However, its action mechanism is yet to be unraveled, especially with respect to its role in the modulation of gut microbiota composition. In the present study, profiles of microbiota in both the cecal and fecal samples from BALB/c mice given respectively the following treatments were examined: normal chow diet (NCD), NCD + fucoxanthin (NCDF), high-fat-diet (HFD), and HFD + fucoxanthin (HFDF). The results showed that fucoxanthin supplementation for 4 weeks significantly changed the composition of both cecal and fecal microbiota. In addition, a differential effect was observed between the supplementation to NCD and to HFD. The changes in the Firmicutes/Bacteroidetes ratio and the abundance of S24-7 and Akkermansia were identified to be among the major gut microbiota modulating events associated with the anti-obesity bioactivity of fucoxanthin. Hence, our results suggested that fucoxanthin could be a promising microbiota-targeted functional-food ingredient.

30 March 2022 in Food & Function
Verified
Journal Article
Closed access
PDF file
THTingyan Hu
Tingyan Hu
JYJunlun Yue
Junlun Yue
QTQiuwen Tang
Qiuwen Tang
Ka-wing ChengKa-wing Cheng
Ka-wing Cheng
FCFeng Chen
Feng Chen
Mingfu WangMingfu Wang
Mingfu Wang
Quercetin, a flavonoid possessing numerous biological activities, is reported to improve renal injury in diabetic animals.

16 November 2020 in Advances in Nutrition
Verified
Journal Article
Closed access
VGVemana Gowd
Vemana Gowd
QKQingzheng Kang
Qingzheng Kang
QWQi Wang
Qi Wang
QWQiang Wang
Qiang Wang
Feng ChenFeng Chen
Feng Chen
Ka-wing ChengKa-wing Cheng
Ka-wing Cheng
Diabetic nephropathy (DN) is a severe complication of diabetes mellitus (DM). Dietary habits play a major role in determining the onset and progression of DM-related disorders and a proper diet (rich in fruits and vegetables) can delay or prevent the process of DM pathogenesis. Thus, increasing attention has been paid to polyphenols and polyphenol-rich foods since their increased intake has been associated with a reduced incidence of DM and its associated complications. Resveratrol is a polyphenolic phytoalexin that is mainly found in grapevines and berries. It is available in various pharmaceutical dosages and is widely recommended as a dietary supplement due to its beneficial effects. Remarkably, resveratrol's capability to effectively lower blood glucose levels without any side effects has been amply demonstrated in many in vitro and in vivo studies. Herein, we comprehensively review and discuss the nephroprotective effect of resveratrol during DN and its associated mechanisms. Resveratrol exerts its nephroprotective effects via various mechanisms including reducing oxidative stress and advanced glycation end-product (AGE) production, stimulating autophagy, inhibiting endoplasmic reticulum (ER) stress and inflammation, ameliorating lipotoxicity, activating the AMP kinase (AMPK) pathway, and modulating angiogenesis. Moreover, the use of resveratrol as an adjuvant to conventional antidiabetic therapies could be an effective approach to manage DN in humans. However, evidence is scarce to support whether resveratrol has beneficial effects in humans during DN. Therefore, clinical studies are warranted to elucidate resveratrol's role against DN.